HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Niger
Niger: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 16.0% in 2014. ◆ Volatile
Latest (2014)
16.0%
Change on year
down 77.5%
World rank
93rd
of 104 countries
All-time high
71.0%
in 2013
All-time low
6.6%
in 2011
Years of data
9
2005–2014
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Niger, 2005–2014
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Niger is 16.0%, measured in 2014.
Compared with earlier readings it is down 77.5% on the previous year and down 62.8% over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Niger peaked at 71.0% in 2013 and was at its lowest, 6.6%, in 2011.
That places Niger 93rd out of 104 countries with data for 2014, putting it in the bottom quarter.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Niger, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 43.0% | — |
| 2007 | 24.0% | -44.2% |
| 2008 | 45.0% | +87.5% |
| 2009 | 24.0% | -46.7% |
| 2010 | 37.0% | +54.2% |
| 2011 | 6.6% | -82.2% |
| 2012 | 31.0% | +369.7% |
| 2013 | 71.0% | +129.0% |
| 2014 | 16.0% | -77.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 34.0% | 24.0% | 45.0% | 4 |
| 2010s | 32.3% | 6.6% | 71.0% | 5 |
Countries ranked near Niger
- 90 Trinidad and Tobago 24.0% compare
- 90 Côte d'Ivoire 24.0% compare
- 92 Iran, Islamic Republic of 20.0% compare
- 94 Malaysia 7.4% compare
- 95 Cuba 4.6% compare
- 96 Tunisia 0.0% compare
- 96 Bhutan 0.0%
- 96 Panama 0.0% compare
- 96 Seychelles 0.0% compare
- 96 Sudan 0.0% compare
- 96 Syrian Arab Republic 0.0% compare
- 96 Bahrain 0.0%
- 96 Barbados 0.0% compare
- 96 Bulgaria 0.0%
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Population ages 15-19, male, annual growth rate 3.68 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.058 units per person (2025)
- Population ages 20-24, female, annual growth rate 4.16 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0454 units per person (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Niger?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Niger was 16.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Niger?
- The highest recorded value was 71.0% in 2013.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Niger?
- The lowest recorded value was 6.6% in 2011.
- How does Niger rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Niger ranks 93rd out of 104 countries with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Niger?
- Over the last ten years it is down 62.8%. The long-run trend across the full record is volatile.
- Where does this Niger data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).